DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma
Bone Marrow Transplant
.
2023 Mar;58(3):334-336.
doi: 10.1038/s41409-022-01887-0.
Epub 2022 Dec 2.
Authors
Anita D'Souza
1
,
Ruta Brazauskas
2
,
Bi Qing Teng
2
,
Grant Yun
3
,
Hannah Uttley
4
,
Jing Dong
4
,
Michael B Dwinell
5
,
Marcelo C Pasquini
4
,
Sergio Giralt
6
,
Heather Landau
6
,
Edward Stadtmauer
7
,
Amrita Krishnan
8
,
Siegfried Janz
4
Affiliations
1
Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. andsouza@mcw.edu.
2
Division of Biostatistics, Insitute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
3
MCW Medical School, Milwaukee, WI, USA.
4
Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
5
Center for Immunology, Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
6
Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
7
Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
8
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA, USA.
PMID:
36460820
DOI:
10.1038/s41409-022-01887-0
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers
DNA Methylation
Humans
Leukocytes
Multiple Myeloma* / genetics
Substances
Biomarkers
Grants and funding
UG1 HL069286/HL/NHLBI NIH HHS/United States
U10 HL069294/HL/NHLBI NIH HHS/United States
K23 HL141445/HL/NHLBI NIH HHS/United States